{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:08:20Z","timestamp":1792382900543,"version":"4.4.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,24]]},"abstract":"<jats:title>Vignette<\/jats:title>\n               <jats:p>A 63-yr-old woman with end-stage CKD secondary to glomerulonephritis, on hemodialysis therapy, presented with scoliosis, back pain, and progressive loss of physical function for which corrective surgery was planned. Optimization of bone health was requested by the surgeon as a DXA scan had revealed osteoporosis at spine, hip, and forearm. Due to previous subtotal parathyroidectomy and normal parathyroid hormone and bone-specific alkaline phosphatase levels, a low bone turnover state was suspected. An iliac bone biopsy was performed and revealed low bone turnover, a mineralization defect, and severe osteoporosis. The patient was treated with calcium and intensified vitamin D supplementation, followed by a 2-yr course of teriparatide. Monitoring of bone turnover markers indicated a bone anabolic response to therapy, and a repeat DXA showed increases in BMD at spine and hip. A repeat biopsy at end of treatment showed normal bone turnover and mineralization. This case demonstrates the complicated bone health of patients with advanced CKD. As there are no randomized trials for fracture pretention in patients with CKD, care must be individualized and is often based on expert opinion. The use of bone biopsy is safe and informative in guiding therapy.<\/jats:p>","DOI":"10.1093\/jbmr\/zjae062","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T21:19:28Z","timestamp":1713388768000},"page":"531-535","source":"Crossref","is-referenced-by-count":4,"title":["Diagnosis and therapeutic decisions of osteoporosis in chronic kidney disease"],"prefix":"10.1093","volume":"39","author":[{"given":"Hanne Skou","family":"J\u00f8rgensen","sequence":"first","affiliation":[{"name":"Institute of Clinical Medicine, University of Aarhus , Aarhus, 8200 , Denmark"},{"name":"Department of Nephrology, Aalborg University Hospital , Aalborg, 9000 , Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Moe","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Indiana University School of Medicine , Indianapolis, IN 46202 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L","family":"Nickolas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center , New York, NY 10032 , United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,17]]},"reference":[{"issue":"1","key":"2024052412553479900_ref1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what's changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"issue":"4","key":"2024052412553479900_ref2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MNH.0000000000000798","article-title":"Clinical utility of bone turnover markers in patients with chronic kidney disease","volume":"31","author":"Smout","year":"2022","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"2024052412553479900_ref3","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1053\/ajkd.2001.27426","article-title":"Skeletal resistance to PTH as a basic abnormality underlying uremic bone diseases","volume":"38","author":"Fukagawa","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"2024052412553479900_ref4","doi-asserted-by":"crossref","first-page":"116482","DOI":"10.1016\/j.bone.2022.116482","article-title":"Vascular calcification of the abdominal aorta has minimal impact on lumbar spine bone density in patients with chronic kidney disease","volume":"162","author":"J\u00f8rgensen","year":"2022","journal-title":"Bone"},{"issue":"6","key":"2024052412553479900_ref5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2215\/CJN.11031017","article-title":"Management of osteoporosis in CKD","volume":"13","author":"Khairallah","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"2024052412553479900_ref6","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semnephrol.2012.12.016","article-title":"Impaired vitamin D metabolism in CKD","volume":"33","author":"Bosworth","year":"2013","journal-title":"Semin Nephrol"},{"issue":"5","key":"2024052412553479900_ref7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.ajkd.2021.07.027","article-title":"Diagnostic accuracy of noninvasive bone turnover markers in renal osteodystrophy","volume":"79","author":"J\u00f8rgensen","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2024052412553479900_ref8","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2024052412553479900_ref9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000316708","article-title":"treatment of hemodialysis-associated adynamic bone disease with teriparatide (pth1-34): a pilot study","volume":"33","author":"Cejka","year":"2010","journal-title":"Kidney Blood Press Res"},{"key":"2024052412553479900_ref10","article-title":"Efficacy and safety of romosozumab among Postmmenopausal Women With Osteoporosis and Mild-to-Moderate Chronic Kidney Disease","volume-title":"J Bone Miner Res.","author":"Miller"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jbmr\/advance-article-pdf\/doi\/10.1093\/jbmr\/zjae062\/57449108\/zjae062.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/39\/5\/531\/57881176\/zjae062.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/39\/5\/531\/57881176\/zjae062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T15:56:19Z","timestamp":1716566179000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/39\/5\/531\/7649227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,17]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,4,17]]},"published-print":{"date-parts":[[2024,5,24]]}},"URL":"https:\/\/doi.org\/10.1093\/jbmr\/zjae062","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,4,17]]}}}